Niko Resources
TSE:NKONiko Resources Ltd. engages in the exploration, development, and production of oil and natural gas in India and Bangladesh. It primarily holds interests in the D6 Block consisting of Dhirubhai 1 and 3 Fields, MA Field, R cluster development project, satellite cluster development project, and MJ field development project located off the coastline of Andhra Pradesh, India; and the Block 9 in the central area of Bangladesh. The company was founded in 1987 and is headquartered in Calgary, Canada.
Oyster Oil and Gas
CVE:OYOyster Oil and Gas Ltd., an upstream oil and gas company, engages in the acquisition, exploration, and development of oil and gas interests in East Africa. It holds a 100% interest in 4 onshore and offshore blocks covering an area of approximately 3.5 million acres in the Republic of Djibouti; and a working interest in an onshore Antsiranana Block 1101 situated in the Republic of Madagascar. The company was formerly known as Clemson Resources Corp. and changed its name to Oyster Oil and Gas Ltd. in April 2013. Oyster Oil and Gas Ltd. is headquartered in Vancouver, Canada.
Protalix BioTherapeutics
NYSE:PLXProtalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell-expressed recombinant PEGylated Uricase which is in Phase I trial for the treatment of gout; and PRX-119, a plant cell-expressed PEGylated recombinant human DNase I product candidate that is in preclinical phase for the treatment of NETs-related diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. The company was incorporated in 1993 and is headquartered in Karmiel, Israel. Protalix BioTherapeutics, Inc. is a subsidiary of Protalix Ltd.
Terrace Energy
CVE:TZRTerrace Energy Corp. does not have significant operations. Previously it was engaged in the acquisition, exploration, and development of conventional onshore oil and gas properties in the United States. The company was formerly known as Terrace Resources Inc. and changed its name to Terrace Energy Corp. in June 2011. Terrace Energy Corp. was incorporated in 2006 and is headquartered in The Woodlands, Texas.